Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Thickening is the fastest growing sector, North America is the largest market

The Global Pharmaceutical Gelatin Market is projected to expand from USD 2.12 Billion in 2025 to USD 3.03 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.13%. This high-molecular-weight biopolymer, derived from the partial hydrolysis of collagen, is crucial for manufacturing hard and soft capsules, serving as a plasma expander, and stabilizing vaccine formulations.

Its growth is primarily fueled by the increasing worldwide incidence of chronic diseases and an expanding elderly population, both of which necessitate effective oral drug delivery systems to boost patient compliance and bioavailability. The material's exceptional functional attributes, such as superior film-forming capabilities and biocompatibility, further solidify its indispensable role in clinical applications. However, this growth is somewhat constrained by the inherent volatility of raw material costs. Notably, in 2025, the health and nutrition sector was identified as the predominant application area, with 54% of surveyed industry professionals operating within this segment, highlighting the critical reliance of both pharmaceutical and nutraceutical industries on this versatile excipient.

Market Drivers

A key driver for the pharmaceutical gelatin market is the escalating demand for softgel and hard capsule delivery systems, which significantly enhance patient compliance by effectively masking taste and facilitating ease of swallowing. Gelatin is fundamental to these dosage forms, providing essential mechanical strength and dissolution properties crucial for securely encapsulating active pharmaceutical ingredients (APIs). This robust demand is reflected in financial reports, such as Nitta Gelatin India Limited's October 2025 statement, which cited a revenue increase to 141.93 crore INR, largely attributable to its pharmaceutical excipient lines.

Concurrently, the rapid expansion of the nutraceutical and dietary supplement industry further propels market growth, driven by consumers' growing preference for preventative health solutions. Manufacturers are increasingly adopting pharmaceutical-grade gelatin for fortified functional foods and gummy supplements, which require precise textural and stability characteristics. This trend is underscored by rising supplement usage, like magnesium's increase to 23% among all supplement users, as reported by the Council for Responsible Nutrition in October 2024. Major producers, such as Nitta Gelatin Inc. with net sales of 18.49 billion JPY for the six months ending September 2025, are sustaining substantial turnover, indicating gelatin's vital role across both clinical and wellness sectors.

Market Challenges

The significant volatility in raw material costs represents a critical challenge for the global pharmaceutical gelatin market, largely due to its heavy reliance on livestock by-products. As a derivative of the meat processing industry, pharmaceutical gelatin is susceptible to various external pressures, including sanitary regulations, animal disease outbreaks, and fluctuations in livestock populations. This dependency creates a fragile supply chain, often leading to sudden price escalations and significant procurement risks for pharmaceutical manufacturers, complicating cost management for essential drug delivery systems and deterring long-term investments in gelatin-based formulations.

This instability in raw material supply directly impedes market scalability by limiting the availability of pharmaceutical-grade excipients needed to meet increasing demand. The issue is compounded by a contraction in livestock numbers in key regions, such as the estimated decline in European porcine production to approximately 218 million heads in 2024, according to Gelatine Manufacturers of Europe (GME). Such supply constraints force manufacturers to operate in a high-cost environment, thereby slowing the broader adoption of gelatin in mass-market pharmaceutical applications, despite its inherent functional advantages.

Market Trends

The market is undergoing a significant transformation with the expansion into regenerative medicine and hemostatic applications, positioning pharmaceutical gelatin as a cornerstone biomaterial for advanced clinical devices. Manufacturers are actively re-engineering gelatin's physicochemical properties to develop innovative solutions like flowable hemostats, wound healing scaffolds, and bio-inks that mimic the extracellular matrix, moving beyond its traditional role in encapsulation.

This strategic shift towards high-value biomedical solutions is supported by substantial capital allocation from leading industry players who are diversifying their portfolios, exemplified by Darling Ingredients' global ingredients business achieving an EBITDA of $248 million in Q3 2025, enabling investments in next-generation medical devices. Additionally, the increasing commercialization of marine-sourced pharmaceutical gelatin is accelerating in response to a growing global demand for non-mammalian excipients, which align with strict Halal, Kosher, and pescatarian dietary requirements. This trend prompts producers to diversify their raw material supply chains beyond bovine and porcine sources to include cold-water fish skins, which offer comparable functional performance while circumventing regulatory hurdles associated with animal diseases. The commercial viability and profitability of adapting production portfolios to these evolving ethno-religious market needs are highlighted by Nitta Gelatin India Limited's reported profit before tax of 109.68 crore INR in its Annual Report 2024-25.

Key Market Players

• Gelita AG
• Trobas Pharmaceutical gelatine B.V
• Rousselot SAS
• Gelatines Weishardt SAS
• Sterling Biotec Ltd.
• Catalent, Inc
• Nitta Pharmaceutical Gelatin India Limited
• Aspire Pharmaceuticals
• Gelco International
• Lapi Gelatine S.p.a

Report Scope

In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Gelatin Market, by Type:

• Type A
• Type B

Pharmaceutical Gelatin Market, by Source:

• Porcine
• Bovine Skin
• Bovine Bone
• Fish
• Poultry

Pharmaceutical Gelatin Market, by Function:

• Stabilizing
• Thickening
• Gelling
• Others

Pharmaceutical Gelatin Market, by End User:

• Hard Capsule
• Soft Capsule
• Tablet
• Absorbable Hemostat
• Others

Pharmaceutical Gelatin Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Gelatin Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.